CCMH
FLNA

Cornerstone Capital Management Holdings’s Filana Therapeutics FLNA Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,600
Closed -$34K – 1477
2015
Q1 		$34K Sell
2,600
-3,329
-56% -$44.9K ﹤0.01% 1330
2014
Q4 		$84K Sell
5,929
-2,114
-26% -$36.6K ﹤0.01% 1178
2014
Q3 		$220K Buy
8,043
+6,800
+547% +$207K ﹤0.01% 1090
2014
Q2 		$50K Buy
+1,243
New +$46K ﹤0.01% 1244

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management Holdings's FLNA Position: Q2 2015 in Review

Cornerstone Capital Management Holdings sold out of Filana Therapeutics (FLNA) in Q2 2015, closing a stake of 2,600 shares — an estimated $34K sold.

Cornerstone Capital Management Holdings first reported a position in FLNA in Q2 2014 and held it in 4 quarters. The position peaked at $220K in Q3 2014. 66 funds tracked by Wall St. Rank hold FLNA as of Q2 2015.

  • Cornerstone Capital Management Holdings reported no remaining Filana Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 2,600 Filana Therapeutics shares in Q2 2015, an estimated $34K.
  • Cornerstone Capital Management Holdings first reported a position in Filana Therapeutics in Q2 2014 and held it in 4 quarters.
  • Cornerstone Capital Management Holdings's Filana Therapeutics position peaked at $220K in Q3 2014.
  • 66 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2015.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2015, filed 11 Aug 2015.